The WACC of Hofseth Biocare ASA (HBC.OL) is 7.0%.
| Range | Selected | |
| Cost of equity | 5.80% - 8.30% | 7.05% |
| Tax rate | 22.00% - 22.00% | 22.00% |
| Cost of debt | 7.00% - 9.40% | 8.20% |
| WACC | 5.7% - 8.2% | 7.0% |
| Category | Low | High |
| Long-term bond rate | 3.3% | 3.8% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.48 | 0.66 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.80% | 8.30% |
| Tax rate | 22.00% | 22.00% |
| Debt/Equity ratio | 0.19 | 0.19 |
| Cost of debt | 7.00% | 9.40% |
| After-tax WACC | 5.7% | 8.2% |
| Selected WACC | 7.0% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for HBC.OL:
cost_of_equity (7.05%) = risk_free_rate (3.55%) + equity_risk_premium (5.60%) * adjusted_beta (0.48) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.